Recently, several studies have demonstrated that H19 is involved in the clinicopathological progression of many different tumor types and is associated with clinical parameters such as tumor size, clinical stage, lymph node metastasis, distant metastasis, and overall survival (OS) 19, 20. This evidence concerns the gene H19 and metastatic malignant neoplasm in the lymph nodes.